High versus low-dose caffeine for apnea of prematurity: a randomized controlled trial

European Journal of Pediatrics

Volumn 174, Issue 7, 2015, Pages 949-956

  Mohammed, Sameh ^a   Nour, Islam ^a,b   Shabaan, Abd Elazeez ^a,b   Shouman, Basma ^a,b   Abdel Hady, Hesham ^a,b   Nasef, Nehad ^a,b  

^a MANSOURA UNIVERSITY CHILDREN S HOSPITAL   (Egypt)

^b MANSOURA UNIVERSITY   (Egypt)

Author keywords

Apnea; Caffeine; Mechanical ventilation; Neonatal respiratory distress syndrome; Preterm infant; Xanthines

Indexed keywords

CAFFEINE CITRATE; CAFFEINE; CENTRAL STIMULANT AGENT; CITRIC ACID;

ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; DRUG WITHDRAWAL; EXTUBATION; FEASIBILITY STUDY; GESTATIONAL AGE; HUMAN; HYPERTENSION; LENGTH OF STAY; LOW DRUG DOSE; MAINTENANCE DRUG DOSE; MAJOR CLINICAL STUDY; NEWBORN; NEWBORN APNEA; OUTCOME ASSESSMENT; OXYGEN THERAPY; PILOT STUDY; POSITIVE END EXPIRATORY PRESSURE; PREMATURITY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TACHYCARDIA; TREATMENT DURATION; WEIGHT GAIN; ADVERSE EFFECTS; APNEA; CHEMICALLY INDUCED; DOSE RESPONSE; EGYPT; FEMALE; HOSPITAL MORTALITY; INFANT, PREMATURE, DISEASES; MALE;

AIRWAY EXTUBATION; APNEA; CAFFEINE; CENTRAL NERVOUS SYSTEM STIMULANTS; CITRATES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EGYPT; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; MALE; PILOT PROJECTS; PROSPECTIVE STUDIES; RESPIRATION, ARTIFICIAL; TACHYCARDIA;

EID: 84931575475     PISSN: 03406199     EISSN: 14321076     Source Type: Journal    
DOI: 10.1007/s00431-015-2494-8     Document Type: Article

References (37)

1. American Academy of Pediatrics CoFaN (2003) Apnea, sudden infant death syndrome, and home monitoring. Pediatrics 111:914–917
2. Bauer J, Maier K, Linderkamp O, Hentschel R (2001) Effect of caffeine on oxygen consumption and metabolic rate in very low birth weight infants with idiopathic apnea. Pediatrics 107:660–663
3. Di Fiore JM, Bloom JN, Orge F, Schutt A, Schluchter M, Cheruvu VK, Walsh M, Finer N, Martin RJ (2010) A higher incidence of intermittent hypoxemic episodes is associated with severe retinopathy of prematurity. J Pediatr 157:69–73
4. Di Fiore JM, Martin RJ, Gauda EB (2013) Apnea of prematurity—perfect storm. Respir Physiol Neurobiol 189:213–222
5. Dobson NR, Hunt CE (2013) Pharmacology review: caffeine use in neonates: indications, pharmacokinetics, clinical effects, outcomes. NeoReviews 14:e540–e550
6. Erenberg A, Leff RD, Haack DG, Mosdell KW, Hicks GM, Wynne BA (2000) Caffeine citrate for the treatment of apnea of prematurity: a double-blind, placebo-controlled study. Pharmacotherapy 20:644–652
7. Ergenekon E, Dalgic N, Aksoy E, Koc E, Atalay Y (2001) Caffeine intoxication in a premature neonate. Paediatr Anaesth 11:737–739
8. Gray PH, Flenady VJ, Charles BG, Steer PA (2011) Caffeine citrate for very preterm infants: effects on development, temperament and behaviour. J Paediatr Child Health 47:167–172
9. Gupta JM, Mercer HP, Koo WW (1981) Theophylline in treatment of apnoea of prematurity. Aust Paediatr J 17:290–291
10. Henderson-Smart D (1986) Pulmonary disease in the newborn. In: Textbook of neonatology. Churchill livingstone, Melbourne
11. Henderson-Smart DJ (1981) The effect of gestational age on the incidence and duration of recurrent apnoea in newborn babies. Aust Paediatr J 17:273–276
12. Henderson-Smart DJ, and Davis PG (2010). Prophylactic methylxanthines for endotracheal extubation in preterm infants. Cochrane Database Syst Rev CD000139
13. Henderson-Smart DJ, and De Paoli AG (2010). Methylxanthine treatment for apnoea in preterm infants. Cochrane Database Syst Rev CD000140
14. Henderson-Smart DJ, and Steer PA (2010). Caffeine versus theophylline for apnea in preterm infants. Cochrane Database Syst Rev CD000273.
15. Hofstetter AO, Legnevall L, Herlenius E, Katz-Salamon M (2008) Cardiorespiratory development in extremely preterm infants: vulnerability to infection and persistence of events beyond term-equivalent age. Acta Paediatr 97:285–292
16. Jobe AH, Bancalari E (2001) Bronchopulmonary dysplasia. Am J Respir Crit Care Med 163:1723–1729
17. Kassim Z, Greenough A, Rafferty GF (2009) Effect of caffeine on respiratory muscle strength and lung function in prematurely born, ventilated infants. Eur J Pediatr 168:1491–1495
18. Kibblewhite D, Sleigh J (1996) Heart rate variability in premature neonates pre and post methylxanthine administration. Pediatr Anesth 6:399–403
19. Kumral A, Tuzun F, Yesilirmak DC, Duman N, Ozkan H (2012) Genetic basis of apnoea of prematurity and caffeine treatment response: role of adenosine receptor polymorphisms: genetic basis of apnoea of prematurity. Acta Paediatr 101:e299–e303
20. Martin RJ, Abu-Shaweesh JM, and Baird TM (2004). Apnoea of prematurity. Paediatr Respir Rev 5 Suppl A: S377-382.
21. Martin RJ, Wang K, Koroglu O, Di Fiore J, Kc P (2011) Intermittent hypoxic episodes in preterm infants: do they matter? Neonatology 100:303–310
22. Mathew OP (2011) Apnea of prematurity: pathogenesis and management strategies. J Perinatol 31:302–310
23. Murat I, Moriette G, Blin MC, Couchard M, Flouvat B, De Gamarra E, Relier JP, Dreyfus-Brisac C (1981) The efficacy of caffeine in the treatment of recurrent idiopathic apnea in premature infants. J Pediatr 99:984–989
24. Peliowski A, Finer NN (1990) A blinded, randomized, placebo-controlled trial to compare theophylline and doxapram for the treatment of apnea of prematurity. J Pediatr 116:648–653
25. Rieg T, Steigele H, Schnermann J, Richter K, Osswald H, Vallon V (2005) Requirement of intact adenosine A1 receptors for the diuretic and natriuretic action of the methylxanthines theophylline and caffeine. J Pharmacol Exp Ther 313:403–409
26. Robertson CM, Watt MJ, Dinu IA (2009) Outcomes for the extremely premature infant: what is new? And where are we going? Pediatr Neurol 40:189–196
27. Scanlon JE, Chin KC, Morgan ME, Durbin GM, Hale KA, Brown SS (1992) Caffeine or theophylline for neonatal apnoea? Arch Dis Child 67:425–428
28. Schmidt B, Anderson PJ, Doyle LW, Dewey D, Grunau RE, Asztalos EV, Davis PG, Tin W, Moddemann D, Solimano A, Ohlsson A, Barrington KJ, Roberts RS (2012) Survival without disability to age 5 years after neonatal caffeine therapy for apnea of prematurity. JAMA 307:275–282
29. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2006) Caffeine therapy for apnea of prematurity. N Engl J Med 354:2112–2121
30. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A, Solimano A, Tin W (2007) Long-term effects of caffeine therapy for apnea of prematurity. N Engl J Med 357:1893–1902
31. Sims ME, Yau G, Rambhatla S, Cabal L, Wu PY (1985) Limitations of theophylline in the treatment of apnea of prematurity. Am J Dis Child 139:567–570
32. Soloveychik V, Bin-Nun A, Ionchev A, Sriram S, Meadow W (2009) Acute hemodynamic effects of caffeine administration in premature infants. J Perinatol 29:205–208
33. Steer P, Flenady V, Shearman A, Charles B, Gray PH, Henderson-Smart D, Bury G, Fraser S, Hegarty J, Rogers Y, Reid S, Horton L, Charlton M, Jacklin R, Walsh A (2004) High dose caffeine citrate for extubation of preterm infants: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 89:F499–F503
34. Steer PA, Flenady VJ, Shearman A, Lee TC, Tudehope DI, Charles BG (2003) Periextubation caffeine in preterm neonates: a randomized dose response trial. J Paediatr Child Health 39:511–515
35. Shah VA, and Wai WC (2011). Effectivenes and side effects of 2 different doses of caffeine citrate in preventing apnea in VLBW premature infants. In: Hot Topics in Neonatology. Washington/DC: Nemours Education
36. Walsh MC, Kliegman RM (1986) Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 33:179–201
37. Zubrow AB, Hulman S, Kushner H, Falkner B (1995) Determinants of blood pressure in infants admitted to neonatal intensive care units: a prospective multicenter study. Philadelphia Neonatal Blood Pressure Study Group. J Perinatol 15:470–479